Key result
Advances in understanding the pathophysiology of thrombotic microangiopathies allow for a more accurate molecular classification, opening perspectives for targeted therapies.
Population
Patients with Thrombotic Microangiopathies, including Thrombotic thrombocytopenic purpura and Hemolytic…
Design
Review
Authors
Loading...
May support molecular classification of thrombotic microangiopathies; leaves open targeted therapy benefits pending prospective trials.
Improved understanding of the pathophysiology of thrombotic microangiopathies enables a more accurate molecular classification, paving the way for targeted therapies.
Coppo et al. (2009) conducted a review in Thrombotic Microangiopathies. Advances in understanding the pathophysiology of thrombotic microangiopathies allow for a more accurate molecular classification, opening perspectives for targeted therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: